West Pharmaceutical Services
West Pharmaceutical Services, Inc. is an American manufacturer of design-driven, high-quality containment and delivery systems for injectable medicines and healthcare products. The company specializes in producing elastomeric closures, component packaging, syringe components, and advanced containment solutions for pharmaceutical and biotechnology drug delivery applications. Its principal revenue drivers are the commercial sale of proprietary component packaging systems, specialized containment devices, and analytical laboratory testing services. The firm serves global pharmaceutical companies, biotechnology developers, and generic drug manufacturers requiring rigorous sterile packaging and drug delivery security. West Pharmaceutical Services holds a leading position in the global healthcare sector as an essential supplier of injectable drug packaging components. The company is headquartered in Exton, Pennsylvania, United States, and its shares are publicly listed on the New York Stock Exchange.
43 of the funds FundTelligence covers report a position in West Pharmaceutical Services.
- Legal name
- West Pharmaceutical Services Inc.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 43
Funds holding West Pharmaceutical Services
- Artisan Global Discovery Fund — Artisan Partners · 3.9 % (largest positions only, September 2026)
- SEB Nordamerikafond Små och Medelstora Bolag — SEB · 3.41 % (full portfolio disclosed, June 2026)
- Fondsfinans Global Helse — Fondsfinans · 3.12 % (full portfolio disclosed, October 2026)
- Hermes US Smid Equity Fund — Federated Hermes · 3.03 % (largest positions only, September 2026)
- Schroder ISF US Smaller Companies Impact — Schroders · 2.83 % (full portfolio disclosed, June 2026)
- Artisan Global Opportunities Fund — Artisan Partners · 2.5 % (largest positions only, September 2026)
- Schroder ISF Global Equity Impact — Schroders · 1.52 % (full portfolio disclosed, June 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 1.43 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 43 funds holding it.